News

Results found (476)
October 5, 2012
Yissum's Atox Bio- A promising Orphan Drug Company (Hebrew)

One of six promising orphan Drugs currently under development in Israel, AB103 was granted Fast Track and Orphan Drug designations by the FDA.

September 10, 2012
FDA fast tracks Atox Bio’s tissue infections treatment

Drug developer Atox Bio announced today that the US Food and Drug Administration (FDA) has granted fast track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).

August 14, 2012
HIV Peptide Packs Cancer Treatment

Hebrew U. medical researchers find a tiny peptide encoded by the HIV virus could hold the key to making cancer therapies more successful.

July 23, 2012
Yissum Introduces a Novel Biocontrol Method for Protecting Plants from...

Novel biocontrol agent is environmentally-friendly, non-toxic and effective for a large variety of plants

July 10, 2012
Yissum Introduces a Novel Method for Treating Cancer Based on a Protein...

 

The novel method uses a peptide derived from HIV to increase the sensitivity of cancer cells to radiotherapy and chemotherapy

 

June 28, 2012
Israel is a Computer-Science Empire

When Scientific American recently wrote about the progress in artificial intelligence, it profiled two IBM supercomputers: Deep Blue, which defeated the world champion Gary Kasparov in chess, and the Jeopardy-winning Watson. The other company it...

June 24, 2012
Israel a great place to do business: entrepreneur

Montreal venture capitalist Matthew Price-Gallagher is bullish on Israel. The successful high-tech entrepreneur has been to the country about 20 times in the last two years, attracted to its refreshing “can-do” approach to business – and...

June 22, 2012
The researchers that prolong plant's life [Hebrew]

Five researchers at the Hebrew University's Faculty of Agriculture reach commercial success through Yissum, the university's technology transfer company. 

June 21, 2012
Portraits of brilliance

The Hebrew University of Jerusalem (HUJ) recently unveiled "Innovators Way," a permanent photo exhibition showcasing 27 university researchers whose genius is behind commercial products that have revolutionized the fields of health, safety,...

June 14, 2012
Novel compounds to activate cannabinoid receptors in immune system wins...

Experimental work by a Hebrew University researcher involving stimulation of a cannabinoid receptor in the immune system has been shown to hold promise for the treatment of many neurological, inflammatory and other...

June 14, 2012
Drexel continues research pact with Hebrew University

The agreement on behalf of the institute was made through Yissum, the technology transfer company of the Hebrew University. The program is designed to fund promising research that can lead to creating improved new health-care products, with the...

June 13, 2012
Products from Israeli universities and hospitals earn $20b sales

Yissum Technology Transfer Company of the Hebrew University of Jerusalem president and CEO Yaacov Michlin added that this activity creates high-quality jobs. He estimated that each $1 million in exports creates 15 jobs.